GlassScriptPhysician profile
Robert Owen Mccabe
NPI 1972596104
$3,513.75
in general payments reported to CMS, 2019-2025
16 companies · $660 in 2025
The $660 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2021: $343 · 2022: $564 · 2023: $435 · 2024: $845 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,939.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $547.68 | 2019-2023 | Krystexxa |
| Kerecis Limited | $444.94 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $305.10 | 2022-2025 | Nuzyra |
| Bioventus LLC | $274.74 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $240.29 | 2023-2025 | General - Pain Management |
| Organogenesis INC. | $224.87 | 2019-2021 | |
| Smith+Nephew, INC. | $210.18 | 2021-2022 | |
| Melinta Therapeutics, LLC | $209.92 | 2019 | |
| Stryker Corporation | $165.77 | 2024 | Ortholoc 2 Lapifuse, Phalinx |
| Tactile Systems Technology INC | $147.84 | 2024 | Flexitouch Plus, Entre Plus |
| Treace Medical Concepts, INC. | $147.41 | 2024 | |
| Next Science LLC | $138.99 | 2024 | Xperience, Surgx, Blastx |
| Amgen INC. | $124.76 | 2024 | Krystexxa |
| Advanced Oxygen Therapy INC. | $118.15 | 2025 | Topical Oxygen Chamber For Extremities |
| Crossroads Extremity Systems, LLC | $108.76 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $104.35 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mccabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.